EICHORCondition: Acute Pain · Sponsor: Vertex Pharmaceuticals Incorporated
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Shoals Medical Trials Inc. | Sheffield, Alabama, United States | — |
| Arizona Research Center | Phoenix, Arizona, United States | — |
| Woodland International Research Group | Little Rock, Arkansas, United States | — |
| Trovare Clinical Research | Bakersfield, California, United States | — |
| New Hope Research Development | Tarzana, CA | Tarzana, California, United States | — |
| Clinical Pharmacology of Miami | Miami, Florida, United States | — |
| ForCare Clinical Research | Tampa, Florida, United States | — |
| Atlanta Center for Medical Research | Atlanta, Georgia, United States | — |
| BioBehavioral Research of Austin | Austin, Texas, United States | — |
| HD Research LLC | First Surgical Hospital | Bellaire, Texas, United States | — |
| HD Research LLC | Legent Orthopedic Hospital | Carrollton, Texas, United States | — |
| Memorial Hermann Village | Houston, Texas, United States | — |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06619847